Authors:
LEDOUSSAL V
BRIFFOD M
SPYRATOS F
BIECHE I
Citation: V. Ledoussal et al., AN UPDATE ON METHODS FOR EXAMINING SMALL SPECIMENS FOR FACTORS INDICATIVE OF PROGNOSIS AND RESPONSE TO TREATMENT, La Semaine des hopitaux de Paris, 74(31-32), 1998, pp. 1175-1177
Authors:
BOUCHET C
SPYRATOS F
HACENE K
DURCOS L
BECETTE V
OGLOBINE J
Citation: C. Bouchet et al., PROGNOSTIC VALUE OF UROKINASE PLASMINOGEN-ACTIVATOR IN PRIMARY BREAST-CARCINOMA - COMPARISON OF 2 IMMUNOASSAY METHODS, British Journal of Cancer, 77(9), 1998, pp. 1495-1501
Citation: F. Spyratos et M. Briffod, DNA-PLOIDY AND S-PHASE FRACTION BY IMAGE AND FLOW-CYTOMETRY IN BREAST-CANCER FINE-NEEDLE CYTOPUNCTURES, Modern pathology, 10(6), 1997, pp. 556-563
Citation: M. Briffod et al., CYTOLOGIC NUCLEAR GRADING OF FINE-NEEDLE CYTOPUNCTURES OF BREAST-CARCINOMA - COMPARISON WITH HISTOLOGIC NUCLEAR GRADING AND IMAGE CYTOMETRIC DATA, Analytical and quantitative cytology and histology, 19(2), 1997, pp. 114-122
Authors:
DELAGE V
DEYTIEUX S
LEDOUSSAL V
DEGORCE F
BELLANGER L
HACENE K
SEGUIN P
DESCOTES F
SAEZ S
SPYRATOS F
Citation: V. Delage et al., COMPARISON OF A NEW MICROPLATE ESTROGEN-RECEPTOR (ER) ENZYME-IMMUNOASSAY WITH OTHER ER DETECTION METHODS, British Journal of Cancer, 76(4), 1997, pp. 519-525
Citation: Jl. Dhautcourt et al., QUALITY-CONTROL STUDY BY THE FRENCH-CYTOMETRY-ASSOCIATION ON FLOW CYTOMETRIC DNA CONTENT AND S-PHASE FRACTION (5-PERCENT) (VOL 26, PG 32, 1996), Cytometry, 26(2), 1996, pp. 183-183
Citation: Jl. Dhautcourt et al., QUALITY-CONTROL STUDY BY THE FRENCH CYTOMETRY ASSOCIATION ON FLOW CYTOMETRIC DNA CONTENT AND S-PHASE FRACTION (S-PERCENT), Cytometry, 26(1), 1996, pp. 32-39
Authors:
ROMAIN S
SPYRATOS F
GOUSSARD J
FORMENTO JL
MAGDELENAT H
Citation: S. Romain et al., IMPROVEMENT OF QUALITY-CONTROL FOR STEROID-RECEPTOR MEASUREMENTS - ANALYSIS OF DISTRIBUTIONS IN MORE THAN 40000 PRIMARY BREAST CANCERS, Breast cancer research and treatment, 41(2), 1996, pp. 131-139
Authors:
BOUCHETBERNET C
SPYRATOS F
ANDRIEU C
DEYTIEUX S
BECETTE V
OGLOBINE J
Citation: C. Bouchetbernet et al., INFLUENCE OF THE EXTRACTION PROCEDURE ON PLASMINOGEN-ACTIVATOR INHIBITOR-2 (PAI-2) AND UROKINASE RECEPTOR (UPAR) ASSAYS IN BREAST-CANCER TISSUES, Breast cancer research and treatment, 41(2), 1996, pp. 141-146
Citation: F. Spyratos, VALIDATION OF TISSUE PARAMETERS - CRITERI A PROPOSED BY THE EORTC RECEPTOR AND BIOMARKER STUDY-GROUP AND THE GROUP OF BIOPATHOLOGIE TISSULAIRE ET MOLECULAIRE (FNCLCC AND SFBC), Bulletin du cancer, 83(12), 1996, pp. 1027-1028
Authors:
PICHON MF
BROET P
MAGDELENAT H
DELARUE JC
SPYRATOS F
BASUYAU JP
SAEZ S
RALLET A
COURRIERE P
MILLON R
ASSELAIN B
Citation: Mf. Pichon et al., PROGNOSTIC VALUE OF STEROID-RECEPTORS AFTER LONG-TERM FOLLOW-UP OF 2257 OPERABLE BREAST CANCERS, British Journal of Cancer, 73(12), 1996, pp. 1545-1551
Authors:
LEDOUSSAL V
TUBIANAHULIN M
HACENE K
SPYRATOS F
LASRY S
GARBAY JR
ROUESSE J
Citation: V. Ledoussal et al., HAVE HISTOLOGICAL GRADE NUCLEAR-COMPONENTS (MSBR) OF SCARFF BLOOM RICHARDSON (SBR) A PROGNOSTIC VALUE FOR LOBULAR INVASIVE BREAST-CARCINOMA, European journal of cancer, 31A, 1995, pp. 666-666
Authors:
PICHON MF
BROET P
MAGDELENAT H
DELARUE JC
SPYRATOS F
BASUYAU JP
SAEZ S
RALLET A
COURRIERE P
MILLON R
ASSELAIN B
Citation: Mf. Pichon et al., PROGNOSTIC VALUE OF STEROID-RECEPTORS AFTER LONG-TERM FOLLOW-UP OF 2257 OPERABLE BREAST-CANCER PATIENTS, European journal of cancer, 31A, 1995, pp. 674-674
Authors:
TUBIANAHULIN M
HACENE K
MARTIN PM
SPYRATOS F
Citation: M. Tubianahulin et al., PROGNOSTIC FACTOR CLUSTERING IN BREAST-CANCER - BIOLOGY OR CHRONOLOGY, European journal of cancer, 31A(2), 1995, pp. 282-283
Authors:
ROMAIN S
SPYRATOS F
LAINEBIDRON C
BOUCHET C
GUIROU O
MARTIN PM
OGLOBINE J
MAGDELENAT H
Citation: S. Romain et al., COMPARATIVE-STUDY OF 4 EXTRACTION PROCEDURES FOR UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN BREAST-CANCER TISSUES, European journal of clinical chemistry and clinical biochemistry, 33(9), 1995, pp. 603-608
Citation: Z. Bouizar et al., PARATHYROID-HORMONE RELATED PROTEIN (PTH-RP) DIFFERENT SPLICING FORMSIN BREAST-CANCER AND THE OCCURRENCE OF METASTASIS TO BONE, Journal of bone and mineral research, 10, 1995, pp. 283-283
Citation: F. Spyratos et S. Romain, TISSULAR PROGNOSTIC FACTORS IN ONCOLOGY - MODALITIES OF EVALUATION AND VALIDATION, Bulletin du cancer, 82(2), 1995, pp. 90-96
Citation: F. Spyratos et S. Romain, TISSULAR PROGNOSTIC FACTORS IN ONCOLOGY - MODALITIES OF EVALUATION AND VALIDATION, Bulletin du cancer, 82(1), 1995, pp. 22-28
Authors:
ROMAIN S
SPYRATOS F
GUIROU O
DEYTIEUX S
CHINOT O
MARTIN PM
Citation: S. Romain et al., TECHNICAL EVALUATION OF THYMIDINE KINASE ASSAY IN CYTOSOLS FROM BREAST CANCERS, European journal of cancer, 30A(14), 1994, pp. 2163-2165
Authors:
COLOMBEL MC
POUS MF
ABBOU CC
VANVELTHOVEN R
BELLOT J
SPYRATOS F
ANDRIEU C
DELAUNOIT Y
CHOPIN DK
Citation: Mc. Colombel et al., COMPUTER-ASSISTED IMAGE-ANALYSIS OF BLADDER-TUMOR NUCLEI FOR MORPHONUCLEAR AND PLOIDY ASSESSMENT, Analytical cellular pathology, 6(2), 1994, pp. 137-147
Authors:
SPYRATOS F
MARTIN PM
HACENE K
ANDRIEU C
ROMAIN S
FLOIRAS JL
MAGDELENAT H
Citation: F. Spyratos et al., PROGNOSTIC VALUE OF A SOLUBILIZED FRACTION OF EGF RECEPTORS IN PRIMARY BREAST-CANCER USING AN IMMUNOENZYMATIC ASSAY - A RETROSPECTIVE STUDY, Breast cancer research and treatment, 29(1), 1994, pp. 85-95
Authors:
BOUCHET C
SPYRATOS F
MARTIN PM
HACENE K
GENTILE A
OGLOBINE J
Citation: C. Bouchet et al., PRONOSTIC VALUE OF UROKINASE-TYPE PLASMIN OGEN-ACTIVATOR (UPA) AND PLASMINOGEN-ACTIVATOR INHIBITORS PAI-1 AND PAI-2 IN BREAST CARCINOMAS, Bulletin du cancer, 81(9), 1994, pp. 770-779